TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 37543062

Group type: EXPERIMENTAL
Intervention: Flamingo device
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional endoscopic techniques
Number of subjects: 36
Study: 37543161

Group type: EXPERIMENTAL
Intervention: Vasopressin and methylprednisolone
Number of subjects: 186

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 186
Study: 37543256

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 3521

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3521

Group type: EXPERIMENTAL
Intervention: SGLT2i
Number of subjects: 3521

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 3521
Study: 37543437

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen (HFNO)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Conventional oxygen treatment with a Venturi mask
Number of subjects: 83
Study: 37543464

Group type: EXPERIMENTAL
Intervention: eTURB
Number of subjects: 384
Study: 37543512

Group type: EXPERIMENTAL
Intervention: exMPC (exercise-aware model predictive control)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: exAPD (exercise-aware adaptive proportional derivative)
Number of subjects: 27
Study: 37543521

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 63
Study: 37543575

Group type: EXPERIMENTAL
Intervention: Intermittent bolus paravertebral block (ropivacaine 0.5% loading, 0.2% infusion)
Number of subjects: 80
Study: 37543587

Group type: EXPERIMENTAL
Intervention: Anlotinib plus icotinib
Number of subjects: 60
Study: 37543590

Group type: EXPERIMENTAL
Intervention: Cognitive stimulation guided by PREVEDEL software for five continuous days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tablet without the PREVEDEL software (Control group)
Number of subjects: 0
Study: 37543602

Group type: EXPERIMENTAL
Intervention: Tear biomarkers (Aβ38, Aβ40, Aβ42, t-tau, p-tau) measured using multiplex immunoassays
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: MRI scan, neuropsychological tests, ophthalmic examination
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Cerebral spinal fluid collection and amyloid PET scan (subset of participants)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Macular pigment optical density measurement and retinal imaging
Number of subjects: 200
Study: 37543639

Group type: EXPERIMENTAL
Intervention: Grip strength (GS) measured using the Martin Vigorimeter, with cut-points derived for dominant hand (DH) and non-dominant hand (NDH) based on 4 definitions of weakness.
Number of subjects: 976
Study: 37543755

Group type: EXPERIMENTAL
Intervention: EVL plus propranolol till eradication of esophageal varices (EEV)
Number of subjects: 212

Group type: COMPARATOR
Intervention: EVL plus continuing propranolol
Number of subjects: 212
Study: 37543959

Group type: EXPERIMENTAL
Intervention: Diabetic Macular Edema (DME)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 82
Study: 37544143

Group type: EXPERIMENTAL
Intervention: Triple antithrombotic treatment consisting of subcutaneous enoxaparin, VKA, and discontinued aspirin
Number of subjects: 308
Study: 37544239

Group type: EXPERIMENTAL
Intervention: Crossword puzzles as an active learning method for three lesson hours following the standard lecture technique.
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard lecture technique as a traditional method.
Number of subjects: 72
Study: 37544326

Group type: EXPERIMENTAL
Intervention: cAd3-EBO S vaccine at 1 × 10^11 viral particles
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: cAd3-EBO S vaccine at 1 × 10^10 viral particles
Number of subjects: 40
Study: 37544410

Group type: EXPERIMENTAL
Intervention: Liso-cel
Number of subjects: 0

Group type: COMPARATOR
Intervention: ASCT
Number of subjects: 0
Study: 37544492

Group type: EXPERIMENTAL
Intervention: Urine chemistry-guided diuretic strategy
Number of subjects: 450

Group type: COMPARATOR
Intervention: Usual care strategy
Number of subjects: 450
Study: 37544691

Group type: EXPERIMENTAL
Intervention: Technology addiction training for 10 weeks
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 82
Study: 37545129

Group type: EXPERIMENTAL
Intervention: Endovenous laser ablation (EVLA) using the ELVeS® Radial® 2ring slim fiber
Number of subjects: 150
Study: 37545290

Group type: EXPERIMENTAL
Intervention: Combination of CYFRA 21-1 and CA 125 biomarkers
Number of subjects: 480

Group type: COMPARATOR
Intervention: Low-risk SD patients
Number of subjects: 480

Group type: COMPARATOR
Intervention: High-risk SD patients
Number of subjects: 480
Study: 37545298

Group type: EXPERIMENTAL
Intervention: Intermittent low-carbohydrate diet (ILCD) - carbohydrate intake ≤ 50 g/d on seven nonconsecutive days
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Intermittent low-carbohydrate diet (ILCD)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Calorie restriction (ICR) - 500-600 kcal/d for two consecutive days per week
Number of subjects: 34
Study: 37545359

Group type: EXPERIMENTAL
Intervention: teleCBIT (8 sessions guided by a manualized protocol)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: teleCBIT
Number of subjects: 0
Study: 37545387

Group type: EXPERIMENTAL
Intervention: DTG + TAF/FTC
Number of subjects: 31

Group type: COMPARATOR
Intervention: Dolutegravir/lamivudine
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 31
Study: 37545392

Group type: EXPERIMENTAL
Intervention: CAP-100 (anti-CCR7 antibody)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Venetoclax
Number of subjects: 0
Study: 37545406

Group type: EXPERIMENTAL
Intervention: Lacosamide (LCM) up to 12 mg/kg/day or 600 mg/day
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Lacosamide (LCM)
Number of subjects: 55
Study: 37545466

Group type: EXPERIMENTAL
Intervention: Water First intervention (classroom lessons, water stations, schoolwide water promotion over 1 school year)
Number of subjects: 1249

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1249
Study: 37545577

Group type: EXPERIMENTAL
Intervention: Double burden of malnutrition (DBM)
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Sex
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: School type
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Minimum dietary diversity score
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Frequency of meals
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Home gardening practice
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: History of illness
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Knowledge of nutrition
Number of subjects: 742
Study: 37545580

Group type: EXPERIMENTAL
Intervention: Early oral feeding (EOF)
Number of subjects: 898

Group type: COMPARATOR
Intervention: Delayed oral feeding (DOF)
Number of subjects: 898
Study: 37545595

Group type: EXPERIMENTAL
Intervention: Mini-Cog screening for preoperative cognitive impairment (scores ≤ 3)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Normal cognitive function (Mini-Cog scores > 3)
Number of subjects: 153
Study: 37545629

Group type: EXPERIMENTAL
Intervention: Complex interactive multimodal intervention including advanced education via mobile connection, participation in a web-based social network, tailored feedback, and support of a nurse coach.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-guided stress management (Control group).
Number of subjects: 0
Study: 37545735

Group type: EXPERIMENTAL
Intervention: rTMS targeting the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: rTMS targeting the left angular gyrus (AG)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Personalized rTMS based on RCT results
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham intervention in longitudinal personalized trial
Number of subjects: 90
Study: 37545861

Group type: EXPERIMENTAL
Intervention: GV1001 1.12 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 37546286

Group type: EXPERIMENTAL
Intervention: Cellular scales in Log2Lose trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EHR weights in MAINTAIN trial
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pragmatic methods in both studies
Number of subjects: 0
Study: 37546352

Group type: EXPERIMENTAL
Intervention: Cerviron
Number of subjects: 0
Study: 37546740

Group type: EXPERIMENTAL
Intervention: 1 μM quercetin for three days
Number of subjects: 0

Group type: COMPARATOR
Intervention: DMSO
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quercetin for 6 months in COPD patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for 6 months in COPD patients
Number of subjects: 0
Study: 37546787

Group type: EXPERIMENTAL
Intervention: Volume control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pressure control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adaptive pressure control
Number of subjects: 0
Study: 37546872

Group type: EXPERIMENTAL
Intervention: VR neuroscience-based therapy (VRNT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 31
Study: 37547219

Group type: EXPERIMENTAL
Intervention: CALMA m-health app
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 37547446

Group type: EXPERIMENTAL
Intervention: High symptom group (FACT-ES score tertile)
Number of subjects: 977

Group type: EXPERIMENTAL
Intervention: Hot flashes
Number of subjects: 977

Group type: EXPERIMENTAL
Intervention: Breast sensitivity
Number of subjects: 977
Study: 37547448

Group type: EXPERIMENTAL
Intervention: Pretreatment tumors
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Posttreatment residual tumors in the breast and lymph nodes after neoadjuvant chemotherapy
Number of subjects: 96
Study: 37547664

Group type: EXPERIMENTAL
Intervention: Gonadotoxic childhood therapy
Number of subjects: 12
Study: 37547785

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 37547856

Group type: EXPERIMENTAL
Intervention: LinkUP (single-session motivational interviewing intervention)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control (attention-matched didactic control condition)
Number of subjects: 149
Study: 37547978

Group type: EXPERIMENTAL
Intervention: Intravenous perampanel (IV)
Number of subjects: 21
Study: 37548010

Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis for acute stroke in the prehospital setting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Advanced prehospital diagnostics for large vessel occlusion and intracranial hemorrhage
Number of subjects: 0
Study: 37548009

Group type: EXPERIMENTAL
Intervention: Ticagrelor-aspirin
Number of subjects: 6336

Group type: COMPARATOR
Intervention: Clopidogrel-aspirin
Number of subjects: 6336
Study: 37548022

Group type: EXPERIMENTAL
Intervention: Arthroscopic repair
Number of subjects: 65

Group type: COMPARATOR
Intervention: Arthroscopic debridement
Number of subjects: 65
Study: 37548085

Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 724
Study: 37548158

Group type: EXPERIMENTAL
Intervention: Surgically closed VSDs
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Unrepaired VSDs
Number of subjects: 30

Group type: COMPARATOR
Intervention: General population
Number of subjects: 30
Study: 37548390

Group type: EXPERIMENTAL
Intervention: Peripheral blood complete remission (PB-CR)
Number of subjects: 1441

Group type: EXPERIMENTAL
Intervention: Complete remission (CR) with additional PB-CR
Number of subjects: 1441
Study: 37548510

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided infraclavicular cannulation of the axillary artery (A group)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Ultrasound-guided cannulation of the common femoral artery (F group)
Number of subjects: 110
Study: 37548555

Group type: EXPERIMENTAL
Intervention: UGN-102 once weekly for 6 weeks
Number of subjects: 282

Group type: COMPARATOR
Intervention: Transurethral resection of bladder tumor monotherapy
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: UGN-102 ± transurethral resection of bladder tumor
Number of subjects: 282

Group type: COMPARATOR
Intervention: Transurethral resection of bladder tumor
Number of subjects: 282
Study: 37548623

Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pump (IABP)
Number of subjects: 5343

Group type: COMPARATOR
Intervention: Control (no IABP)
Number of subjects: 5343
Study: 37548683

Group type: EXPERIMENTAL
Intervention: vCVP-st (with standardized inspiratory maneuver)
Number of subjects: 63

Group type: COMPARATOR
Intervention: vCVP-ns (without standardized inspiratory maneuver)
Number of subjects: 63
Study: 37548804

Group type: EXPERIMENTAL
Intervention: EC aerosol with nicotine
Number of subjects: 22

Group type: COMPARATOR
Intervention: EC aerosol without nicotine
Number of subjects: 22
Study: 37548831

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab (n=66)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Chemotherapy (n=77)
Number of subjects: 143
Study: 37548850

Group type: EXPERIMENTAL
Intervention: Intrathecal bevacizumab (IT BEV)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Intravenous bevacizumab (IA BEV)
Number of subjects: 1
Study: 37548968

Group type: EXPERIMENTAL
Intervention: Targeted hypothermia at 33 °C
Number of subjects: 1861

Group type: COMPARATOR
Intervention: Targeted normothermia (37.8 °C or higher)
Number of subjects: 1861
Study: 37548980

Group type: EXPERIMENTAL
Intervention: 2 yes or no questions for estimating pack-year eligibility
Number of subjects: 0
Study: 37548984

Group type: EXPERIMENTAL
Intervention: Regular BP cuff
Number of subjects: 195

Group type: COMPARATOR
Intervention: Too-small BP cuff
Number of subjects: 195

Group type: COMPARATOR
Intervention: Too-large BP cuff
Number of subjects: 195

Group type: COMPARATOR
Intervention: Appropriate BP cuff
Number of subjects: 195
Study: 37548983

Group type: EXPERIMENTAL
Intervention: Digital plain language recommendation (PLR) format
Number of subjects: 268

Group type: COMPARATOR
Intervention: Standard language version (SLV)
Number of subjects: 268
Study: 37549004

Group type: EXPERIMENTAL
Intervention: Engagement in a mobile peer support community using an app for tracking steps (n=93)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Using the app for step tracking only (n=93)
Number of subjects: 202
Study: 37549139

Group type: EXPERIMENTAL
Intervention: Anodal high-definition transcranial direct current stimulation (1mA for 20 min)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Cathodal high-definition transcranial direct current stimulation (1mA for 20 min)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Sham high-definition transcranial direct current stimulation (1mA for 20 min)
Number of subjects: 105
Study: 37549192

Group type: EXPERIMENTAL
Intervention: Bnt162b2 vaccine (3 doses)
Number of subjects: 26
Study: 37549351

Group type: EXPERIMENTAL
Intervention: Patients with active acromegaly
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Acromegaly treatment
Number of subjects: 26
Study: 37549370

Group type: EXPERIMENTAL
Intervention: Knee hyperextension group (study group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no knee hyperextension)
Number of subjects: 40
Study: 37549385

Group type: EXPERIMENTAL
Intervention: Social Needs Case Management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 37549428

Group type: EXPERIMENTAL
Intervention: ADS Plus (intervention)
Number of subjects: 203

Group type: COMPARATOR
Intervention: ADS (control)
Number of subjects: 203
Study: 37549442

Group type: EXPERIMENTAL
Intervention: Maternal magnetic resonance imaging (MRI) studies of the placenta at 14-16 weeks gestational age (GA)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Maternal magnetic resonance imaging (MRI) studies of the placenta at 19-24 weeks gestational age (GA)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: MRI indices showing decreased placental volume, perfusion, and oxygenation
Number of subjects: 199
Study: 37549532

Group type: EXPERIMENTAL
Intervention: Crizotinib
Number of subjects: 24
Study: 37549598

Group type: EXPERIMENTAL
Intervention: LCPUFA-ω3 supplementation (225 mg DHA, 45 mg EPA, administered at 0.100 g/kg of body weight/day for 3 months)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo group (500 mg sunflower oil)
Number of subjects: 72
Study: 37549675

Group type: EXPERIMENTAL
Intervention: Perfluorocarbons (PFCs) used as oxygen carriers and red blood cell substitutes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PFCs as adjunct in cancer therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PFCs for donor organ perfusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PFCs as airway mechanotransducers
Number of subjects: 0
Study: 37549680

Group type: EXPERIMENTAL
Intervention: CoronaVac (third dose)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: BNT162b2 (third dose)
Number of subjects: 451
Study: 37549724

Group type: EXPERIMENTAL
Intervention: Bedside family planning counseling and offer of contraception (oral contraceptive pills, etonogestrel implant, or medroxyprogesterone injection)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Flyer recommending discussion with outpatient physician about contraception
Number of subjects: 76

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 76
Study: 37549753

Group type: EXPERIMENTAL
Intervention: EUS-CDS
Number of subjects: 144

Group type: COMPARATOR
Intervention: ERCP-M
Number of subjects: 144
Study: 37549836

Group type: EXPERIMENTAL
Intervention: Ovarian tissue cryopreservation via laparoscopic unilateral ovariectomy
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Ovarian tissue cryopreservation
Number of subjects: 106
Study: 37549923

Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine
Number of subjects: 0
Study: 37549933

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.5 mg/5 mL in Mucolox™
Number of subjects: 29

Group type: COMPARATOR
Intervention: Dexamethasone 0.5 mg/5 mL solution (standard arm)
Number of subjects: 29
Study: 37549979

Group type: EXPERIMENTAL
Intervention: Automated fibrosis score calculation and electronic reminder messages
Number of subjects: 1061

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1061
Study: 37550019

Group type: EXPERIMENTAL
Intervention: Single-dose oral secnidazole 2 g
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study: 37550025

Group type: EXPERIMENTAL
Intervention: High subjective cognitive impairment group
Number of subjects: 200

Group type: COMPARATOR
Intervention: Low subjective cognitive impairment group
Number of subjects: 200
Study: 37550123

Group type: EXPERIMENTAL
Intervention: Intravascular imaging-guided PCI (IVUS or OCT)
Number of subjects: 1507

Group type: COMPARATOR
Intervention: Angiography-guided PCI
Number of subjects: 1507
Study: 37550129

Group type: EXPERIMENTAL
Intervention: Breastfeeding Problems Management Model (BPMM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 50
Study: 37550157

Group type: EXPERIMENTAL
Intervention: Elevated serum alkaline phosphatase (ALP) quartile Q4 (ALP >83.00 U/L)
Number of subjects: 22989
Study: 37550314

Group type: EXPERIMENTAL
Intervention: Ulotaront
Number of subjects: 0
Study: 37550429

Group type: EXPERIMENTAL
Intervention: Blinatumomab (immunotherapy drug)
Number of subjects: 0
Study: 37550634

Group type: EXPERIMENTAL
Intervention: Neoadjuvant mFOLFIRINOX followed by surgery and adjuvant mFOLFIRINOX (8 cycles neoadjuvant and 4 cycles adjuvant)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Adjuvant mFOLFIRINOX (only)
Number of subjects: 378
Study: 37550656

Group type: EXPERIMENTAL
Intervention: General practitioner health care utilization (HCU)
Number of subjects: 17822

Group type: EXPERIMENTAL
Intervention: Psychologist/Psychiatrist health care utilization (HCU)
Number of subjects: 17822

Group type: EXPERIMENTAL
Intervention: Psychiatric hospital services health care utilization (HCU)
Number of subjects: 17822

Group type: EXPERIMENTAL
Intervention: Prognostic models for long-term psychologist/psychiatrist and psychiatric hospital HCU
Number of subjects: 17822

Group type: EXPERIMENTAL
Intervention: Overall health care utilization trends
Number of subjects: 17822
Study: 37550693

Group type: EXPERIMENTAL
Intervention: Patients with stress-related disorders (adjustment disorder and exhaustion disorder)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Patients with exhaustion disorder
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Self-reported memory impairment
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Self-reported burnout symptoms
Number of subjects: 266

Group type: COMPARATOR
Intervention: Healthy normative group
Number of subjects: 266
Study: 37550703

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo remote ischemic conditioning
Number of subjects: 44
Study: 37550711

Group type: EXPERIMENTAL
Intervention: Proximal Row Carpectomy (PRC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Four-Corner Arthrodesis (FCA)
Number of subjects: 0
Study: 37550727

Group type: EXPERIMENTAL
Intervention: Bony decompression with duroplasty
Number of subjects: 222

Group type: COMPARATOR
Intervention: Bony decompression alone
Number of subjects: 222
Study: 37550730

Group type: EXPERIMENTAL
Intervention: Adapted TranS-C
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Standard TranS-C
Number of subjects: 130

Group type: COMPARATOR
Intervention: Usual care followed by delayed treatment with TranS-C (UC-DT)
Number of subjects: 130
Study: 37550740

Group type: EXPERIMENTAL
Intervention: Theoretical training plus simulation-based training (4 centers)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Theoretical training alone (4 centers)
Number of subjects: 8
Study: 37550831

Group type: EXPERIMENTAL
Intervention: Caregiver contribution to self-care maintenance
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Patient self-care maintenance
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Caregiver contribution to self-care management
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Overall model
Number of subjects: 510
Study: 37550942

Group type: EXPERIMENTAL
Intervention: mRNA vaccination
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: non-mRNA vaccination
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: serologic evidence of viral exposure
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: ozanimod treatment
Number of subjects: 288